These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 28434351)

  • 1. End-stage renal failure due to transthyretin amyloidosis after liver transplantation: outcomes in 19 registry cases.
    Rocha A; Beirão I; Pessegueiro H; Almeida R; Lobato L
    Amyloid; 2017 Mar; 24(sup1):85-86. PubMed ID: 28434351
    [No Abstract]   [Full Text] [Related]  

  • 2. End-stage renal disease in familial amyloidosis ATTR Val30Met: a definitive indication to combined liver-kidney transplantation.
    Lobato L; Ventura A; Beirão I; Miranda HP; Seca R; Henriques AC; Teixeira M; Sarmento AM; Pereira MC
    Transplant Proc; 2003 May; 35(3):1116-20. PubMed ID: 12947881
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of liver transplantation and tafamidis in hereditary transthyretin amyloidosis caused by transthyretin Leu55Pro mutation: a case report.
    Kon T; Misumi Y; Nishijima H; Honda M; Suzuki C; Baba M; Inomata Y; Obayashi K; Ando Y; Tomiyama M
    Amyloid; 2015; 22(3):203-4. PubMed ID: 26123280
    [No Abstract]   [Full Text] [Related]  

  • 4. Outcomes of Patients With Familial Transthyretin Amyloidosis After Liver Transplantation.
    Banerjee D; Roeker LE; Grogan M; Swiecicki P; Poterucha J; Heimbach J; Zeldenrust S; Gertz M; Edwards B; Daly R; Klarich KW; Dispenzieri A
    Prog Transplant; 2017 Sep; 27(3):246-250. PubMed ID: 29187090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. End-stage renal disease and dialysis in hereditary amyloidosis TTR V30M: presentation, survival and prognostic factors.
    Lobato L; Beirão I; Silva M; Fonseca I; Queirós J; Rocha G; Sarmento AM; Sousa A; Sequeiros J
    Amyloid; 2004 Mar; 11(1):27-37. PubMed ID: 15185496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Familial amyloid polyneuropathies: therapeutic issues].
    Adams D; Cauquil C; Théaudin M
    Bull Acad Natl Med; 2012 Oct; 196(7):1333-45; discussion 1345-7. PubMed ID: 23815018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic but asymptomatic transthyretin amyloidosis 8 years after domino liver transplantation.
    Koike H; Kiuchi T; Iijima M; Ueda M; Ando Y; Morozumi S; Tomita M; Kawagashira Y; Watanabe H; Katsuno M; Shimoyama Y; Okazaki Y; Kamei H; Sobue G
    J Neurol Neurosurg Psychiatry; 2011 Nov; 82(11):1287-90. PubMed ID: 20935325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapidly Progressive Transthyretin-Mediated Amyloidosis in a Domino Liver Transplant Recipient of a Ser23Asn Donor.
    Dixit N; Castano A; Farr MJ; Traub R; Lentzsch S; Brown RS; Maurer MS; Brannagan TH
    J Clin Neuromuscul Dis; 2016 Mar; 17(3):142-5. PubMed ID: 26905915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitreous amyloidosis in two sisters as the indication of transthyretin-related familial form of systemic amyloidosis among liver transplantation candidates.
    Niemczyk R; Brydak-Godowska J; Kecik D; Wagner T; Lewandowski P; Kecik M; Zygier D; Ołdakowska-Jedynak U
    Transplant Proc; 2009 Oct; 41(8):3085-7. PubMed ID: 19857683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-reported gastrointestinal symptoms are more common in liver transplanted transthyretin amyloidosis patients than in healthy controls and in patients transplanted for end-stage liver disease.
    Marberg T; Karling P; Söderberg K; Anan I; Wixner J
    Amyloid; 2019; 26(sup1):47-48. PubMed ID: 31343318
    [No Abstract]   [Full Text] [Related]  

  • 11. Transthyretin amyloidosis and the kidney.
    Lobato L; Rocha A
    Clin J Am Soc Nephrol; 2012 Aug; 7(8):1337-46. PubMed ID: 22537653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver transplantation and transthyretin amyloidosis.
    Benson MD
    Muscle Nerve; 2013 Feb; 47(2):157-62. PubMed ID: 23169427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poor outcome after liver transplantation for transthyretin amyloid neuropathy in a family with an Ala36Pro transthyretin mutation: case report.
    Muller KR; Padbury R; Jeffrey GP; Poplawski NK; Thompson P; Tonkin A; Harley HA
    Liver Transpl; 2010 Apr; 16(4):470-3. PubMed ID: 20373457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of long-term survival after liver transplantation for familial transthyretin amyloidosis.
    Algalarrondo V; Antonini T; Théaudin M; Ducot B; Lozeron P; Chemla D; Benmalek A; Lacroix C; Azoulay D; Castaing D; Cauquil C; Rouzet F; Dinanian S; Eliahou L; Le Guludec D; Samuel D; Slama MS; Adams D
    J Am Coll Cardiol; 2015 Nov; 66(19):2154-2156. PubMed ID: 26541929
    [No Abstract]   [Full Text] [Related]  

  • 15. Outcome in patients treated with isolated liver transplantation for familial transthyretin amyloidosis to prevent cardiomyopathy.
    Nelson LM; Penninga L; Villadsen GE; Mølgaard H; Eiskjaer H; Hillingsø JG; Rasmussen A
    Clin Transplant; 2015 Dec; 29(12):1098-104. PubMed ID: 26361241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kidney Transplantation in Systemic Amyloidosis.
    Angel-Korman A; Havasi A
    Transplantation; 2020 Oct; 104(10):2035-2047. PubMed ID: 32053574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Model for end-stage liver disease (MELD) exception for familial amyloidotic polyneuropathy.
    Pomfret E; Gish RG; Brandhagen D
    Liver Transpl; 2006 Dec; 12(12 Suppl 3):S100-1. PubMed ID: 17123281
    [No Abstract]   [Full Text] [Related]  

  • 18. Occurrence factors and clinical picture of iatrogenic transthyretin amyloidosis after domino liver transplantation.
    Misumi Y; Oshima T; Ueda M; Yamashita T; Tasaki M; Masuda T; Obayashi K; Ando Y
    Amyloid; 2017 Mar; 24(sup1):123-124. PubMed ID: 28434312
    [No Abstract]   [Full Text] [Related]  

  • 19. Combined heart and liver transplantation for familial amyloidotic neuropathy.
    Pilato E; Dell'Amore A; Botta L; Arpesella G
    Eur J Cardiothorac Surg; 2007 Jul; 32(1):180-2. PubMed ID: 17449267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Domino liver transplantation: full-length transthyretin in donor and recipient patients with ATTR Val30Met amyloidosis.
    Westermark P; Nowak G; Suhr OB; Ericzon BG
    Amyloid; 2017 Mar; 24(sup1):128-129. PubMed ID: 28434334
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.